|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Hormonal long-acting methods for contraception. |
| British Journal of Family Planning. 1991 Jan;16(4 Suppl):8-11. |
| Systems for the non-oral administration of low-dose progestogens--injectables, implants, vaginal rings, and IUDs--are |
| being developed in an effort to increase the efficacy of progestogen-only methods with a minimum of side effects. |
| Other advantages of non-oral hormonal contraceptives include high compliance, long duration of action, continuous |
| steady-state blood levels of the steroid, and avoidance of the first-pass effect through the liver. At present, depot |
| medroxyprogesterone acetate and norethisterone enanthate are the most widely used injectable progestogens. |
| These drugs are particularly suitable for women who require a long-term, effective contraceptive method but are |
| unable to tolerate estrogen. Disadvantages include the slow return to fertility (up to 6 months after discontinuation) |
| and disruption of menstrual bleeding patterns--issues that must be addressed in counseling potential acceptors. |
| Slow-release systems for steroid delivery, such as the Norplant subdermal implant, do not require an initially high |
| plasma level of progestogen and thus have greater reversibility than injectables. To date, no method is free of the |
| bleeding disturbances that seem to be associated with the absence of luteal activity. There are some indications |
| that estrogen administration can be useful in the management of bleeding disturbances, however. (PubHealth.info |
| Document ID: CONT3T 2050-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Hormonal long-acting methods for contraception.", is(are) |
| Odlind V. The source of this article is "British Journal of Family Planning. 1991 Jan;16(4 Suppl):8-11.". This article |
| was published in 1991 in English language(s). (PubHealth.info® Document ID: CONT3T 2050-06. All rights reserved |
| with PubHealth.info) PIN: 12050 |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |